Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Dr Enrique Soto - The University of Colorado Anschutz Medical Campus, Colorado...

About ecancer ( Dr Enrique Soto - The University of Colorado Anschutz Medical Campus, Colorado, USA )

Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable...

Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands

Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable advanced melanoma ( Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands )

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate...

Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou )

No benefit for adjuvant durvalumab in completely resected NSCLC

Prof Glenwood Goss - University of Ottawa, Ottawa, Canada

No benefit for adjuvant durvalumab in completely resected NSCLC ( Prof Glenwood Goss - University of Ottawa, Ottawa, Canada )

PFS increase but no OS increase for niraparib in advanced ovarian cancer

Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra...

PFS increase but no OS increase for niraparib in advanced ovarian cancer ( Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra, Madrid, Spain )

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer

Dr Hiroshi Kitamura - University of Toyama, Toyama, Japan

Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer ( Dr Hiroshi Kitamura - University of Toyama, Toyama, Japan )

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer

Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer ( Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium )

Faecal microbiota transplantation increases activity of immunotherapy in mRCC

Dr Chiara Ciccarese - Fondazione Policlinico Universitario Agostino Gemelli...

Faecal microbiota transplantation increases activity of immunotherapy in mRCC ( Dr Chiara Ciccarese - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy )

Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal...

Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada

Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )

Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity...

Prof Gottfried Konecny - University of California, Los Angeles, USA

Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers ( Prof Gottfried Konecny - University of California, Los Angeles, USA )

Total neoadjuvant treatment without surgery for locally advanced rectal cancer

Dr Alessio Amatu - Niguarda Cancer Center, Milan, Italy

Total neoadjuvant treatment without surgery for locally advanced rectal cancer ( Dr Alessio Amatu - Niguarda Cancer Center, Milan, Italy )

More from ecancer